programma definitivo - SocietÃ italiana di neurologia

More documents

Recommendations

Info

4 N O V E M B R E • A R E A P O S T E R 337. PARKINSONIAN SIGNS IN NONDEMENTED SUBJECTS WITH SUBJECTIVE MEMORY COMPLAINTS AND DEPRESSIVE SYMPTOMS: POPULATION- BASED DATA FROM THE ZABÙT AGING PROJECT R. MONASTERO, C. CAMARDA, A. ARONICA, R. CAMARDA (Palermo) 338. PREDICTION OF ALZHEIMER’S DISEASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT USING CSF BIOMARKERS E. RUBINO, A. VACCA, S. ROSSETTI, M. VIGLIANI, D. IMPERIALE, L. GASTALDI, S. PASTORELLI, P. FERRERO, L. PINESSI, I. RAINERO (Torino) 339. LONG-LASTING CHANGES OF PLASMA AMINO ACIDS IN TRANSIENT GLOBAL AMNESIA G. SANCESARIO, Z. ESPOSITO, A. MOZZI, G. M. SANCESARIO, A. MARTORANA, A. GIORDANO, G. SPALLETTA, M. G. MARCIANI, S. BERNARDINI (Roma, Verona) 340. CSF BIOMARKERS IN THE DIAGNOSTIC ASSESSMENT OF SUBJECTIVE MEMORY COMPLAINTS M.G. GALLI, V. LISETTI, N. SALVADORI, D. CHIASSERINI, S. MASTROCOLA, C. PADIGLIONI, P. CALABRESI, L. PARNETTI (Perugia) 341. EFFICACY OF 3R THERAPY VERSUS ROT IN PEOPLE WITH DEMENTIA M. MARIANETTI, S. PINNA, S. TAMBURELLO, M. CARDARELLI, A. VENUTI (Genzano <strong>di</strong> Roma - RM, Roma) 342. TOWARD THE VALIDATION OF CORE ALZHEIMER BIOMARKERS IN THE CLINICAL SETTING A. PICCO, E. CAPELLO, S. MORBELLI, L. ROCCATAGLIATA, F. FAMA’, M. PARDINI, J. ACCARDO, D. ARNALDI, M. FERRARA, F. NOBILI (Genova) 343. ANOSOGNOSIA AND BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS IN PATIENTS WITH ALZHEIMER’S DISEASE AFFECT CAREGIVER BURDEN. A MULTIDIMENSIONAL TEST ASSESSMENT L. TOMASELLO, L. R. PISANI, S. BENINCASA, M. RAFFAELE (Messina, Ragusa) 344. PREDICTORS OF DECLINING MINI-MENTAL STATE IN VALSERIANA SUPERIORE M. CAMERLINGO, S. MARELLI, L. PEREGO, S. D’ASERO, F. ROGGERINI, V. BRANCATO (Osio Sotto - BG, Bergamo) 345. THE ASSOCIATION BETWEEN RETINAL PATHOLOGY AND COGNITIVE FUNCTIONS IN PATIENTS WITH WHITE MATTER LESIONS S. CANDELA, S. CONFORTI, B. CASOLLA, M. CAVALLARI, A. DE CAROLIS, F. ORZI (Roma) 346. PARTICIPATION TO A PSYCHO-EDUCATIONAL AND SUPPORT PROGRAM CONTRIBUTES TO IMPROVE THE QUALITY OF LIFE OF PATIENTS WITH ALZHEIMER’S DISEASE AND THEIR CAREGIVERS L. TOMASELLO, L. R. PISANI, S. BENINCASA, M. RAFFAELE (Messina, Ragusa) 347. WHAT DO WE TALK ABOUT WHEN WE TALK ABOUT MMSE: INTER AND INTRA OPERATOR VARIABILITY B. DIJK, S. LUCARINI, P. CAVAGNARO, C. SERRATI, P. ODETTI (Genova, Chiavari - GE) 348. THE ICT USE IN THE U.V.A. CENTERS FOR BETTER MANAGEMENT OF PATIENTS AND RESOURCES T. TASSINARI, E. SACCHI, S. LANZA, S. BONISSONI, S. TONINI, M. TRUCCO, A. SUGO, E. COCO, F. CENTANARO, P. LANTERI, M. BANDETTINI DI POGGIO (Pietra Ligure - SV) 349. LISTENING TO INDIVIDUALIZED MUSIC AND MUSIC THERAPY IN DEMENTIA: A CROSSOVER STUDY A. RAGLIO, D. BELLANDI, P. BAIARDI, M. GIANOTTI, C. UBEZIO, E. GRANIERI (Pavia, Ferrara, Cremona) 350. D2 AGONIST ADMINISTRATION RESTORES IMPAIRED LTP-LIKE CORTICAL PLASTICITY IN AD PATIENTS G. KOCH, F. DI LORENZO, S. BONNI, C. CALTAGIRONE, A. MARTORANA (Roma) 156
351. RAPIDLY PROGRESSIVE FRONTOTEMPORAL DEMENTIA DUE TO THE PROGRANULIN GENE ARG110X MUTATION L. GHEZZI, A. PIETROBONI, A. ARIGHI, G. FUMAGALLI, C. DONELLI, A. CALVI, C. FENOGLIO, M. SERPENTE, E. RIDOLFI, D. GALIMBERTI, E. SCARPINI (Milano) 352. COGNITIVE IMPAIRMENT IS A NEGATIVE SHORT-TERM AND LONG- TERM PROGNOSTIC FACTOR IN ELDERLY PATIENTS WITH HIP FRACTURE V. GINEX, E. MARIANI, A. ZATI, A. COTTI, F. CLERICI, M. BENEDETTI (Milano, Bologna) 353. CEREBROSPINAL FLUID AND NEUROIMAGING BIOMARKERS IN POSTERIOR CORTICAL ATROPHY A. ARIGHI, D. GALIMBERTI, A. PIETROBONI, M. DE RIZ, G. FUMAGALLI, L. GHEZZI, C. DONELLI, A. CALVI, A. CALLEA, S. ZAGO, E. ROTONDO, P. CORTI, M. MERCURIO, R. VIMERCATI, C. FENOGLIO, E. RIDOLFI, M. RANGO, E. SCARPINI (Milano) 354. CORPUS CALLOSUM CHANGES PREDICT PATHOLOGY PROGRESSION IN ALZHEIMER’S DISEASE M. DI PAOLA, O. PHILLIPS, M. ORFEI, F. PIRAS, C. CACCIARI, C. CALTAGIRONE, G. SPALLETTA (L’Aquila, Roma) 355. A MULTICENTRE, RANDOMISED, OPEN-LABEL, COMPARATIVE PHASE 4 TRIAL TO ASSESS CHANGES IN DEMENTIA DIAGNOSTIC CATEGORY AND DIAGNOSTIC CONFIDENCE AFTER DATSCAN IMAGING IN SUBJECTS WITH AN UNCERTAIN DIAGNOSIS OF DEMENTIA WITH LEWY BODIES (POSSIBLE DLB) R. CERAVOLO, A. ALBERICI, M. BANICA, T. CATTARUZZA, L. KIFERLE, S. MAZZUCCHI, E. PREMI, A. PADOVANI, G. PIZZOLATO, U. BONUCCELLI (Pisa, Brescia, Trieste) 356. POSTERIOR CORTICAL ATROPHY (PCA) AN UNRECOGNIZED HETEROGENEOUS ENTITY S. BAIARDI, M. GIANNOCCARO, S. CAPELLARI, R. GALLASSI, R. PODA, P. AVONI, P. PARCHI, R. LIGUORI (Bologna) DISORDINI DEL MOVIMENTO 2 Moderatori G. FABBRINI (Roma) - M. MATTIOLI (Milano) 4 N O V E M B R E • A R E A P O S T E R 357. OCCIPITAL CORTEX ALPHA ACTIVITY LATERALIZATION CORRELATES WITH L-DOPA MOTOR RESPONSE IN PARKINSON’S DISEASE G. MOSTILE, V. DIBILIO, A. LUCA, I. PAPPALARDO, L. GIULIANO, C. CICERO, G. SCIACCA, L. RACITI, D. CONTRAFATTO, E. BRUNO, V. SOFIA, A. NICOLETTI, M. ZAPPIA (Catania) 358. SWITCHING L-DOPA THERAPY FROM “PULSATILE” TO “PULSE” REDUCES WEARING-OFF AND DYSKINESIA IN COMPLICATED PARKINSON’S DISEASE. A WAKING DAY MONITORING STUDY G. MOSTILE, A. NICOLETTI, V. DIBILIO, A. LUCA, L. RACITI, G. SCIACCA, D. CONTRAFATTO, E. BRUNO, M. ZAPPIA (Catania) 359. THE USEFUL OF QUANTITATIVE GAIT ANALYSIS IN EVALUATING THE LOCOMOTOR PERFORMANCE IN PATIENTS WITH PARKINSON DISEASE M. SERRAO, S. MARI, C. CONTE, G. MARTINO, A. RANAVOLO, G. SANDRINI, R. DI FABIO, F. PIERELLI (Latina, Roma, Monte Porzio Catone - RM, Pavia) 157
Page 1:
2 5
Page 7 and 8:
Sotto l’Alto Patronato della Pres
Page 9 and 10:
CONSIGLIO DIRETTIVO SIN Presidente
Page 11 and 12:
IN TRENO Stazione Centrale - Stazio
Page 13:
Accademia Nazionale di Medicina 16
Page 16 and 17:
AUDITORIUM SALA SILVER 12.30 - 13.3
Page 18 and 19:
2 N O V E M B R E • S A L A G I A
Page 20 and 21:
2 N O V E M B R E • S A L A CORSO
Page 22 and 23:
Page 24 and 25:
2 N O V E M B R E • CORSO A.N.I.N
Page 26 and 27:
2 N O V E M B R E • S A L A SIMPO
Page 28 and 29:
2 N O V E M B R E • S A L A B L U
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
DOMENICA 3 NOVEMBRE AUDITORIUM SALA
Page 36 and 37:
3 N O V E M B R E • A U D I T O R
Page 38 and 39:
Page 40 and 41:
3 N O V E M B R E • S A L A R O S
Page 42 and 43:
3 N O V E M B R E • COMUNICAZIONI
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
3 N O V E M B R E • S A L A B I A
Page 50 and 51:
3 N O V E M B R E • S A L A RIUNI
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
3 N O V E M B R E • S A L A WORKS
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
LUNEDI 4 NOVEMBRE AUDITORIUM SALA S
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
4 N O V E M B R E • COMUNICAZIONI
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
4 N O V E M B R E • LETTURA ore 1
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
MARTEDI 5 NOVEMBRE AUDITORIUM SALA
Page 102 and 103:
5 N O V E M B R E • S A L A BREAK
Page 104 and 105:
Page 106 and 107:
Page 108 and 109: 5 N O V E M B R E • S A L A B L U
Page 110 and 111: 5 N O V E M B R E • S A L A G I A
Page 114 and 115: 5 N O V E M B R E • S A L A T U R
Page 116 and 117: 5 N O V E M B R E • S A L A TRIAL
Page 118 and 119: 5 N O V E M B R E • S A L A WORKS
Page 120 and 121: 5 N O V E M B R E • S A L A WORKS
Page 124 and 125: 5 N O V E M B R E • S A L A B I A
Page 126 and 127: 5 N O V E M B R E • CHIUSURA DEI
Page 128 and 129: 3 N O V E M B R E • A R E A P O S
Page 152 and 153: 150
Page 194 and 195: 5 N O V E M B R E • A R E A 754.
Page 200 and 201: SEGRETERIA IN SEDE CONGRESSUALE La
Page 202 and 203: ACCREDITAMENTO ECM La Commissione N
Page 204 and 205: CERTIFICATO ECM Fin quando non era
Page 207 and 208: Si ringraziano, per l’indispensab
Page 209 and 210:
SI RINGRAZIANO PER LA PARTECIPAZION
Page 212:
SEGRETERIA ORGANIZZATIVA SIN Studio
show all

programma definitivo - SocietÃ italiana di neurologia

Create successful ePaper yourself

Delete template?

Save as template?